Marchiafava‑Bignami Disease: The Importance of Early Diagnosis and Treatment by a Multidisciplinary Team
DOI:
https://doi.org/10.51338/rppsm.2020.v6.i1.120Keywords:
Alcohol‑Related Disorders, Corpus Callosum/diagnostic imaging, Marchiafava‑Bignami Disease/diagnosis, Marchiafava‑Bignami Disease/drug therapyAbstract
Marchiafava‑Bignami disease is a rare condition associated with chronic alcohol consumption and/or malnutrition, characterized by demyelination of the corpus callosum, generally attributed to a deficiency in B complex vitamins. We report the case of a 34‑year‑old male with a 10‑year history of alcohol dependence who was admitted to the hospital, after having been found lying on the floor of his house, malnourished and with pressure ulcers on his chest and knees. On clinical observation he was found to be alert but mute. He followed some simple orders. Generalized spastic hypertonia was present. Magnetic resonance imaging showed demyelination of the corpus callosum, suggesting the diagnosis of Marchiafava‑Bignami disease. He was admitted to the Psychiatry Inpatient Unit and evaluated by a multidisciplinary team. He received thiamine, corticosteroids and rehabilitation. After a week, his speech was slurred but comprehensible and he could walk with aid; magnetic resonance imaging findings had improved. After three months in a Convalescence Unit, he was discharged with total autonomy.
Downloads
References
Sehgal V, Kesav P, Modi M, et al. Acute Marchiafava-Bignami disease presenting as reversible dementia in a chronic alcoholic. BMJ Case Rep Published online 2013 Feb 15. doi: 10.1136/bcr-2012-008286
Marchiafava E, Bignami A. Sopra un alterazione del corpo calloso osservata in soggetti alcoolisti. Riv Patol Nerv Ment 1903;8:544–549
Pérez Álvarez AI, Carbajo CR, de la Tassa GM, Gómez JP. Diabetes mellitus mal controlada como desencadenante de un caso de enfermedad de Marchiafava-Bignami. Neurología 2015;15:S0213–S4853 doi: 10.1016/j.nrl.2015.01.001
Yadala S, Luo JJ. Marchiafava-bignami disease in a nonalcoholic diabetic patient. Case Rep Neurol Med 2013;2013: 1–4. Published online 2013 Apr 24. doi: 10.1155/2013/979383
Kilinc O, Ozbek D, Ozkan E, Midi I. Neurological and psychiatric findings of marchiafava-bignami disease in a nonalcoholic diabetic patient with high blood glucose levels. J Neuropsychiatry Clin Neurosci 2015; 27: e149–e150. doi: 10.1176/appi.neuropsych.14030056.
Suzuki Y, Oishi M, Ogawa K, et al. A patient with Marchiafava–Bignami disease as a complication of diabetes mellitus treated effectively with cortico steroid. J Clin Neurosci. 2012 May;19(5):761-2. doi: 10.1016/j.jocn.2011.07.040.
Bachar M, Fatakhov E, Banerjee C, et al. Rapidly Resolving Nonalcoholic Marchiafava-Bignami Disease in the Setting of Malnourishment After Gastric Bypass Surgery. J Investig Med High Impact Case Rep. 2018 Jun 28;6:2324709618784318. doi: 10.1177/2324709618784318
Takahashi N, Kawamura M, Kobayashi Y. A Case of Nonalcoholic Marchiafava-Bignami Disease with Left-Right Differential Agraphia of Chinese Characters. Case Rep Neurol 2018 Aug 29;10(2):232-241. doi: 10.1159/000492528
Fernandes LMP, Bezerra FR, Monteiro MC, et al. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity: how poor nutrition contributes to the alcoholic syndrome, as Marchiafava–Bignami disease. Eur J Clin Nutr 2017 May;71(5):580-586. doi: 10.1038/ejcn.2016.267
Dong X, Bai C, Nao J. Clinical and radiological features of Marchiafava–Bignami disease. Medicine (Baltimore) 2018 Feb;97(5):e9626. doi: 10.1097/MD.0000000000009626
Brion S. Marchiafava-Bignami disease. In: Vinken PJ, Bruyn GW (eds). Handbook of Clinical Neurology. Oxford, Amsterdam: The Netherlands, 1977; pp 317–329
Kumar KS, Challam R, Naveen J, et al. Marchiafava-Bignami Disease: A Case Report. J Clin Diagn Res 2014 Aug;8(8):RD01-2. doi: 10.7860/JCDR/2014/8377.4668
Hillbom M, Saloheimo P, Fujioka S, et al. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry 2014 Feb;85(2):168-73. doi: 10.1136/jnnp-2013-305979
Bano S, Mehra S, Yadav SN, Chaudhary V. Marchiafava-Bignami disease: Role of neuroimaging in the diagnosis and management of acute disease. Neurol India 2009 Sep-Oct;57(5):649-52. doi: 10.4103/0028-3886.57811
Wenz H, Eisele P, Artemis D, et al. Acute Marchiafava-Bignami Disease with Extensive Diffusion Restriction and Early Recovery: Case Report and Review of the Literature. J Neuroimaging 2014 Jul-Aug;24(4):421-4. doi: 10.1111/j.1552-6569.2012.00755.x
Muccio CF, De Lipsis L, Belmonte R, et al. Reversible MR Findings in Marchiafava-Bignami Disease. Case Rep Neurol Med 2019 Feb 6;2019:1951030. doi: 10.1155/2019/1951030
Gramaglia C, Feggi A, Vecchi C, et al. Marchiafava-Bignami Disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms: a case report. Riv Psichiatr 2016 Mar-Apr;51(2):79-82. doi: 10.1708/2246.24202.
Kim MJ, Kim JK, Yoo BG, et al. Acute Marchiafava-Bignami Disease with Widespread Callosal and Cortical Lesions. J Korean Med Sci 2007;22:908-11. doi: 10.3346/jkms.2007.22.5.908
Nishijima H, Suzuki C, Nunomura JI, et al. Bifrontal cortical lesions in Marchiafava-Bignami disease. Neurology and Clinical Neuroscience 2015;3:3159–160. doi:10.1111/ncn3.170
Ihn YK, Hwang SS, Park YH. Acute Marchiafava-Bignami Disease: Diffusion-Weighted MRI in Cortical and Callosal Involvement. Yonsei Medical Journal 2007;48(2):321–324. doi: 10.3349/ymj.2007.48.2.321
Yoshizaki T, Hashimoto T, Fujimoto K, et al. Evolution of Callosal and Cortical Lesions on MRI in Marchiafava-Bignami Disease. Case Rep Neurol 2010;2(1):19–23. doi: 10.1159/000296705
Namekawa M, Nakamura Y, Nakano I. Cortical involvement in Marchiafava-Bignami disease can be a predictor of a poor prognosis: a case report and review of the literature. Intern Med 2013; 52: 811–3. doi: 10.2169/internalmedicine.52.9336
Wang Z, Wang J, Yi F, et al. Gadolinium Enhancement May Indicate a Condition at Risk of Developing Necrosis in Marchiafava–Bignami Disease: A Case Report and Literature Review. Front Hum Neurosci 2019;13:79. doi: 10.3389/fnhum.2019.00079
Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J Neurol 2004;251:1050–1059. doi: 10.1007/s00415-004-0566-1
Aggarwal A, Khandelwal A, Jiloha RC. A case of Marchiafava-Bignami disease: complete recovery with thiamine. J Neuropsychiatry Clin Neurosci 2011;23(2):E28. doi: 10.1176/appi.neuropsych.23.2.E28.
Nemlekar SS, Mehta RY, Dave KR, et al. Marchiafava: Bignami Disease Treated with Parenteral Thiamine. Indian J Psychol Med 2016:Mar-Apr;38(2):147-9. doi: 10.4103/0253-7176.178810.
Mehrzad R, Ho MG. Mutism Caused by Severe Demyelination in a Patient With Marchiafava-Bignami Disease. J Emerg Med. 2016 Dec;51(6):e129-e132. doi: 10.1016/j.jemermed.2016.07.007.
Canepa C, Arias L. Partial interhemispheric disconnection syndrome (P-IHDS) secondary to Marchiafava-Bignami disease type B (MBD-B). BMJ Case Rep Published online 2016 Nov 23. doi: 10.1136/bcr-2016-216823
Tsai CY, Huang PK, Huang P. Simultaneous acute Marchiafava–Bignami disease and central pontine myelinolysis: A case report of a challenging diagnosis. Medicine 2018;97:8(e9878). Published online 2018 Feb 23. doi: 10.1097/MD.0000000000009878
Dujmović I, Nikolić I, Gavrić-Kezić M, et al. Teaching neuroImages: reversible widespread brain MRI lesions in Marchiafava-Bignami disease. Neurology 2015;84:e81–e82. doi: 10.1212/WNL.0000000000001373
Consoli A, Pirritano D, Bosco D, et al. Corticosteroid treatment in a patient with Marchiafava–Bignami Disease. Neurol Sci 2014; 35: 1143–1145. doi: 10.1007/s10072-014-1705-9
Tao H, Kitagawa N, Kako Y, et al. A case of anorexia nervosa with Marchiafava-Bignami disease that responded to high-dose intravenous corticosteroid administration. Psychiatry Res 2007;156:181–4. doi: 10.1016/j.pscychresns.2007.04.013
Gerlach A, Oehm E, Wattchow J, et al. Use of high-dose cortisone in a patient with Marchiafava-Bignami disease. J Neurol 2003;250:758–60
Kikkawa Y, Takaya Y. Niwa, N. A case of Marchiafava-Bignami disease that responded to high-dose intravenous corticosteroid administration (in Japanese with English abstract). Rinsho Shinkeigaku 2000;40:1122–5
Carrilho PEM, dos Santos MBM, Piasecki L, et al. Marchiafava-Bignami disease: a rare entity with a poor outcome. Rev Bras Ter Intensiva 2013 Mar;25(1):68-72